These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16682983)

  • 1. Should we use incidence, survival or mortality to assess breast cancer trends in European women?
    Sant M; Francisci S; Capocaccia R; Verdecchia A; Allemani C; Berrino F
    Nat Clin Pract Oncol; 2006 May; 3(5):228-9. PubMed ID: 16682983
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes.
    Törnberg S; Kemetli L; Lynge E; Helene Olsen A; Hofvind S; Wang H; Anttila A; Hakama M; Nyström L
    Acta Oncol; 2006; 45(5):528-35. PubMed ID: 16864165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Breast cancer: disparities in Europe].
    Nau JY
    Rev Med Suisse; 2010 Sep; 6(261):1682-3. PubMed ID: 20939404
    [No Abstract]   [Full Text] [Related]  

  • 4. Service screening with mammography in Northern Sweden: effects on breast cancer mortality - an update.
    Jonsson H; Bordás P; Wallin H; Nyström L; Lenner P
    J Med Screen; 2007; 14(2):87-93. PubMed ID: 17626708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of trends in incidence and mortality rates of breast cancer, incidence to mortality ratio and stage at diagnosis between Arab and Jewish women in Israel, 1979-2002.
    Tarabeia J; Baron-Epel O; Barchana M; Liphshitz I; Ifrah A; Fishler Y; Green MS
    Eur J Cancer Prev; 2007 Feb; 16(1):36-42. PubMed ID: 17220702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening mammography and its significance for decreasing breast cancer mortality].
    Frischbier HJ
    Z Arztl Fortbild (Jena); 1991 Oct; 85(20):995-9. PubMed ID: 1776292
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress in the early identification of breast cancer, Rhode Island, 1987-1998.
    Fulton JP; Darcy D
    Med Health R I; 2000 Apr; 83(4):121-2. PubMed ID: 10821015
    [No Abstract]   [Full Text] [Related]  

  • 11. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The University of Rochester model of breast cancer detection and survival.
    Hanin LG; Miller A; Zorin AV; Yakovlev AY
    J Natl Cancer Inst Monogr; 2006; (36):66-78. PubMed ID: 17032896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the impact of breast cancer screening in South Australia.
    Tallis GM; O'Neill TJ
    Intern Med J; 2009 Mar; 39(3):174-8. PubMed ID: 19383066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening: successes and challenges.
    Evans WP
    CA Cancer J Clin; 2012; 62(1):5-9. PubMed ID: 22252587
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of hormone replacement therapy on the incidence of breast cancer in Norway.
    Bakken K; Lund E; Eggen AE
    J Clin Oncol; 2005 May; 23(15):3636-7; author reply 3637-8. PubMed ID: 15908680
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of breast cancer screening in the world.
    Morimoto T; Nagao T; Okazaki K; Kira M; Nakagawa Y; Tangoku A
    Breast Cancer; 2009; 16(1):2-9. PubMed ID: 18841333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
    Zackrisson S; Janzon L; Manjer J; Andersson I
    J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in breast cancer during three decades in Denmark: stage at diagnosis, surgical management and survival.
    Jensen AR; Madsen AH; Overgaard J
    Acta Oncol; 2008; 47(4):537-44. PubMed ID: 18465319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.
    Verkooijen HM; Koot VC; Fioretta G; van der Heiden M; Schipper ME; Rapiti E; Peeters PH; Peterse JL; Bouchardy C
    Breast Cancer Res Treat; 2008 Feb; 107(3):389-95. PubMed ID: 17431760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Breast cancer mortality versus breast cancer survival].
    Zahl PH; Maehlen J
    Tidsskr Nor Laegeforen; 2010 Feb; 130(3):261. PubMed ID: 20160765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.